Henry Schein, Inc. (HSIC)

$70.86

+0.89

(+1.27%)

Market is closed - opens 7 PM, 22 Apr 2024

Insights on Henry Schein, Inc.

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 3.16B → 3.01B (in $), with an average decrease of 4.6% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 140.0M → 18.0M (in $), with an average decrease of 44.5% per quarter

  • Vs MCK

    In the last 1 year, Mckesson Corporation has given 46.1% return, outperforming this stock by 60.7%

  • Vs MCK

    In the last 3 years, Mckesson Corporation has given 169.8% return, outperforming this stock by 169.3%

Performance

  • $70.05
    $70.98
    $70.86
    downward going graph

    1.14%

    Downside

    Day's Volatility :1.31%

    Upside

    0.17%

    downward going graph
  • $60.01
    $85.39
    $70.86
    downward going graph

    15.31%

    Downside

    52 Weeks Volatility :29.72%

    Upside

    17.02%

    downward going graph

Returns

PeriodHenry Schein, Inc.Sector (Health Care)S&P500
3 Months
-5.32%
-0.4%
2.6%
6 Months
3.73%
8.5%
17.6%
1 Year
-14.64%
4.2%
20.3%
3 Years
0.48%
13.9%
20.1%

Highlights

Market Capitalization
9.0B
Book Value
$28.28
Earnings Per Share (EPS)
3.16
PE Ratio
22.14
PEG Ratio
1.65
Wall Street Target Price
79.91
Profit Margin
3.37%
Operating Margin TTM
1.39%
Return On Assets TTM
4.53%
Return On Equity TTM
8.88%
Revenue TTM
12.3B
Revenue Per Share TTM
94.47
Quarterly Revenue Growth YOY
-10.5%
Gross Profit TTM
3.8B
EBITDA
943.0M
Diluted Eps TTM
3.16
Quarterly Earnings Growth YOY
-0.62
EPS Estimate Current Year
5.07
EPS Estimate Next Year
5.63
EPS Estimate Current Quarter
0.7
EPS Estimate Next Quarter
1.09

Analyst Recommendation

Hold
    10%Buy
    63%Hold
    26%Sell
Based on 19 Wall street analysts offering stock ratings for Henry Schein, Inc.(by analysts ranked 0 to 5 stars)
Based on 19 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
2
2
8
Hold
12
12
12
Sell
5
5
2

Analyst Forecast

What analysts predicted

Upside of 12.77%

Current $70.86
Target $79.91

Company Financials

FY18Y/Y Change
Revenue
13.2B
↑ 5.94%
Net Income
535.9M
↑ 31.89%
Net Profit Margin
4.06%
↑ 0.8%
FY19Y/Y Change
Revenue
10.0B
↓ 24.36%
Net Income
520.8M
↓ 2.82%
Net Profit Margin
5.22%
↑ 1.16%
FY20Y/Y Change
Revenue
10.1B
↑ 1.34%
Net Income
403.8M
↓ 22.47%
Net Profit Margin
3.99%
↓ 1.23%
FY21Y/Y Change
Revenue
12.4B
↑ 22.55%
Net Income
631.0M
↑ 56.27%
Net Profit Margin
5.09%
↑ 1.1%
FY22Y/Y Change
Revenue
12.6B
↑ 1.98%
Net Income
538.0M
↓ 14.74%
Net Profit Margin
4.25%
↓ 0.84%
FY23Y/Y Change
Revenue
12.3B
↓ 2.44%
Net Income
416.0M
↓ 22.68%
Net Profit Margin
3.37%
↓ 0.88%
Q3 FY22Q/Q Change
Revenue
3.1B
↑ 1.22%
Net Income
150.0M
↓ 6.25%
Net Profit Margin
4.89%
↓ 0.39%
Q4 FY22Q/Q Change
Revenue
3.4B
↑ 9.91%
Net Income
47.0M
↓ 68.67%
Net Profit Margin
1.39%
↓ 3.5%
Q1 FY23Q/Q Change
Revenue
3.1B
↓ 9.23%
Net Income
121.0M
↑ 157.45%
Net Profit Margin
3.95%
↑ 2.56%
Q2 FY23Q/Q Change
Revenue
3.1B
↑ 1.31%
Net Income
140.0M
↑ 15.7%
Net Profit Margin
4.52%
↑ 0.57%
Q3 FY23Q/Q Change
Revenue
3.2B
↑ 2.0%
Net Income
137.0M
↓ 2.14%
Net Profit Margin
4.33%
↓ 0.19%
Q4 FY23Q/Q Change
Revenue
3.0B
↓ 4.59%
Net Income
18.0M
↓ 86.86%
Net Profit Margin
0.6%
↓ 3.73%
FY18Y/Y Change
Total Assets
8.5B
↑ 8.82%
Total Liabilities
5.0B
↑ 19.35%
FY19Y/Y Change
Total Assets
7.2B
↓ 15.87%
Total Liabilities
3.5B
↓ 28.99%
FY20Y/Y Change
Total Assets
7.8B
↑ 8.69%
Total Liabilities
3.8B
↑ 7.59%
FY21Y/Y Change
Total Assets
8.5B
↑ 9.12%
Total Liabilities
4.4B
↑ 16.62%
FY22Y/Y Change
Total Assets
8.6B
↑ 1.48%
Total Liabilities
3.9B
↓ 10.91%
FY23Y/Y Change
Total Assets
10.6B
↑ 22.84%
Total Liabilities
5.4B
↑ 37.7%
Q3 FY22Q/Q Change
Total Assets
8.5B
↑ 2.52%
Total Liabilities
3.7B
↑ 6.12%
Q4 FY22Q/Q Change
Total Assets
8.6B
↑ 0.86%
Total Liabilities
3.9B
↑ 5.64%
Q1 FY23Q/Q Change
Total Assets
8.6B
↓ 0.41%
Total Liabilities
3.9B
↓ 1.55%
Q2 FY23Q/Q Change
Total Assets
9.1B
↑ 6.7%
Total Liabilities
4.1B
↑ 6.84%
Q3 FY23Q/Q Change
Total Assets
9.8B
↑ 7.26%
Total Liabilities
4.7B
↑ 13.74%
Q4 FY23Q/Q Change
Total Assets
10.6B
↑ 7.78%
Total Liabilities
5.4B
↑ 15.1%
FY18Y/Y Change
Operating Cash Flow
684.7M
↑ 25.52%
Investing Cash Flow
-193.0M
↓ 43.63%
Financing Cash Flow
-603.8M
↑ 436.45%
FY19Y/Y Change
Operating Cash Flow
654.1M
↓ 4.47%
Investing Cash Flow
-424.4M
↑ 119.93%
Financing Cash Flow
-216.0M
↓ 64.23%
FY20Y/Y Change
Operating Cash Flow
598.9M
↓ 8.44%
Investing Cash Flow
-115.0M
↓ 72.9%
Financing Cash Flow
-187.2M
↓ 13.33%
FY21Y/Y Change
Operating Cash Flow
709.6M
↑ 18.48%
Investing Cash Flow
-677.2M
↑ 488.79%
Financing Cash Flow
-333.0M
↑ 77.88%
FY22Y/Y Change
Operating Cash Flow
602.0M
↓ 15.16%
Investing Cash Flow
-276.0M
↓ 59.24%
Financing Cash Flow
-315.0M
↓ 5.39%
Q3 FY22Q/Q Change
Operating Cash Flow
98.0M
↓ 37.58%
Investing Cash Flow
-152.0M
↑ 375.0%
Financing Cash Flow
74.0M
↓ 155.64%
Q4 FY22Q/Q Change
Operating Cash Flow
254.0M
↑ 159.18%
Investing Cash Flow
-65.0M
↓ 57.24%
Financing Cash Flow
-194.0M
↓ 362.16%
Q1 FY23Q/Q Change
Operating Cash Flow
27.0M
↓ 89.37%
Investing Cash Flow
-39.0M
↓ 40.0%
Financing Cash Flow
21.0M
↓ 110.82%
Q2 FY23Q/Q Change
Operating Cash Flow
274.0M
↑ 914.81%
Investing Cash Flow
-301.0M
↑ 671.79%
Financing Cash Flow
38.0M
↑ 80.95%

Technicals Summary

Sell

Neutral

Buy

Henry Schein, Inc. is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Henry Schein, Inc.
Henry Schein, Inc.
-5.24%
3.73%
-14.64%
0.48%
15.41%
Cardinal Health, Inc.
Cardinal Health, Inc.
-3.31%
17.11%
35.09%
77.22%
139.04%
Cencora Inc
Cencora Inc
-1.13%
26.69%
33.67%
87.89%
119.93%
Mckesson Corporation
Mckesson Corporation
-1.12%
15.91%
46.08%
169.79%
366.64%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Henry Schein, Inc.
Henry Schein, Inc.
22.14
22.14
1.65
5.07
0.09
0.05
NA
28.28
Cardinal Health, Inc.
Cardinal Health, Inc.
42.06
42.06
0.31
7.29
0.0
0.03
0.02
-14.13
Cencora Inc
Cencora Inc
23.39
23.39
1.58
11.93
2.34
0.03
0.01
3.39
Mckesson Corporation
Mckesson Corporation
23.48
23.48
4.96
27.6
0.0
0.04
0.0
-15.62
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Henry Schein, Inc.
Henry Schein, Inc.
Hold
$9.0B
15.41%
22.14
3.37%
Cardinal Health, Inc.
Cardinal Health, Inc.
Hold
$25.8B
139.04%
42.06
0.3%
Cencora Inc
Cencora Inc
Buy
$38.5B
119.93%
23.39
0.66%
Mckesson Corporation
Mckesson Corporation
Buy
$68.2B
366.64%
23.48
0.99%

Institutional Holdings

  • Vanguard Group Inc

    11.81%
  • Generation Investment Management LLP

    9.31%
  • BlackRock Inc

    7.74%
  • State Street Corporation

    5.06%
  • Amvescap Plc.

    4.50%
  • American Century Companies Inc

    4.29%

Company Information

henry schein, inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. the company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. a fortune 500® company and a member of the s&p 500® and nasdaq 100® indexes, henry schein employs more than 18,000 team schein members and serves more than one million customers. the company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. henry schein operates through a centralized and automated distribution network, with a selection of more than 100,000 branded products and henry schein private-brand products in stock, as well as more than 150,000 additional products available as special-order items. the company also offers its customers exclusive, innovative technology solutions, including practice

Organization
Henry Schein, Inc.
Employees
25000
CEO
Mr. Stanley M. Bergman
Industry
Wholesale Trade

FAQs